Similar articles

• [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].

  Grassi V, Porcellati C, Corea L, Todisco T. Grassi V, et al. Minerva Nefrol. 1968 Jul-Aug;15(4):258-60. Minerva Nefrol. 1968. PMID: 5745815 Italian. No abstract available.
• Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.

  Radó JP, Sawinsky I, Juhos E. Radó JP, et al. Int J Clin Pharmacol Biopharm. 1976 Oct;14(3):163-7. Int J Clin Pharmacol Biopharm. 1976. PMID: 1002353
• [Diuretics in cirrhosis. Accidents. Indications].

  Andrieu J, Lesueur G. Andrieu J, et al. Presse Med (1893). 1969 Mar 29;77(16):575-8. Presse Med (1893). 1969. PMID: 5783378 French. No abstract available.
• The management of ascites and hyponatremia in cirrhosis.

  Ginès P, Cárdenas A. Ginès P, et al. Semin Liver Dis. 2008 Feb;28(1):43-58. doi: 10.1055/s-2008-1040320. Semin Liver Dis. 2008. PMID: 18293276 Review.
• [Predictable, desirable and undesirable effects of the diuretic treatment].

  Muller AF. Muller AF. Schweiz Med Wochenschr. 1968 May 18;98(20):737-43. Schweiz Med Wochenschr. 1968. PMID: 4884126 Review. French. No abstract available.